Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
← catalyst calendarNCT07546682 · readout ≤ 284 d
Sponsored by Medtronic (industry) · MDT — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
100estimated
Sites
1
Country
Japan
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Apr 2026 | estimated | When the study began enrolling |
| Primary completion | May 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2026-04-23 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Rhinosinusitis (CRS)
Intervention
- Other: None, observational standard of care study
Primary outcome
what the primary-completion date above is the date OFSNOT-22 total score change
measured baseline to month 3
Permalink · MDT's whole pipeline · Catalyst calendar · Every registered study · What changed